ERBB2 and neoplasm: It is possible to hypothesize that these conditions are more likely to occur in patients with lymph node involvement, including younger age, larger tumor size, higher Ki67 level, HR+, HER2+, luminal B and HER2-positive subtypes, and higher grade.